226 related articles for article (PubMed ID: 26822118)
1. Synergistic growth inhibitory effect of deracoxib with doxorubicin against a canine mammary tumor cell line, CMT-U27.
Bakirel T; Alkan FÜ; Üstüner O; Çinar S; Yildirim F; Erten G; Bakirel U
J Vet Med Sci; 2016 May; 78(4):657-68. PubMed ID: 26822118
[TBL] [Abstract][Full Text] [Related]
2. In vitro effects of doxorubicin and deracoxib on oxidative-stress-related parameters in canine mammary carcinoma cells.
Ustün Alkan F; Bakirel T; Ustüner O; Yardibi H
Acta Vet Hung; 2014 Sep; 62(3):372-85. PubMed ID: 25038953
[TBL] [Abstract][Full Text] [Related]
3. The effects of piroxicam and deracoxib on canine mammary tumour cell line.
Ustün Alkan F; Ustüner O; Bakırel T; Cınar S; Erten G; Deniz G
ScientificWorldJournal; 2012; 2012():976740. PubMed ID: 23251109
[TBL] [Abstract][Full Text] [Related]
4. Algerian Propolis Potentiates Doxorubicin Mediated Anticancer Effect Against Human Pancreatic PANC-1 Cancer Cell Line through Cell Cycle Arrest, Apoptosis Induction and P-Glycoprotein Inhibition.
Rouibah H; Kebsa W; Lahouel M; Zihlif M; Ahram M; Aburmeleih B; Mustafa E; Al-Ameer HJ
Anticancer Agents Med Chem; 2018; 18(3):375-387. PubMed ID: 29318976
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Effects of Mitoquinone via Cell Cycle Arrest and Apoptosis in Canine Mammary Gland Tumor Cells.
Lee R; Lee WY; Park HJ
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732133
[TBL] [Abstract][Full Text] [Related]
6. Response of cultured normal canine mammary epithelial cells to deracoxib-doxorubicin combination.
Bakirel T; Ustun Alkan F; Ustuner O; Çinar S; Anlas C; Bilge Sari A
Acta Vet Hung; 2017 Sep; 65(3):366-381. PubMed ID: 28956484
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors.
Saito T; Tamura D; Asano R
Oncol Rep; 2014 Apr; 31(4):1637-44. PubMed ID: 24503782
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclooxygenase inhibitors in a xenograft model of canine mammary tumours.
Sonzogni-Desautels K; Knapp DW; Sartin E; Doré M
Vet Comp Oncol; 2011 Sep; 9(3):161-71. PubMed ID: 21848619
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib exerts antitumor effects in canine mammary tumor cells via COX‑2‑independent mechanisms.
Tamura D; Saito T; Murata K; Kawashima M; Asano R
Int J Oncol; 2015 Mar; 46(3):1393-404. PubMed ID: 25571853
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
[TBL] [Abstract][Full Text] [Related]
11. Canine heat shock protein 27 promotes proliferation, migration, and doxorubicin resistance in the canine cell line DTK-F.
Lin AC; Liao CW; Lin SW; Huang CY; Liou CJ; Lai YS
Vet J; 2015 Aug; 205(2):254-62. PubMed ID: 25882637
[TBL] [Abstract][Full Text] [Related]
12. Combination of celecoxib and doxorubicin increases growth inhibition and apoptosis in acute myeloid leukemia cells.
Chen C; Xu W; Wang CM
Leuk Lymphoma; 2013 Nov; 54(11):2517-22. PubMed ID: 23452119
[TBL] [Abstract][Full Text] [Related]
13. Modulation of P-glycoprotein-mediated doxorubicin resistance in canine cell lines.
Page RL; Hughes CS; Huyan S; Sagris J; Trogdon M
Anticancer Res; 2000; 20(5B):3533-8. PubMed ID: 11131658
[TBL] [Abstract][Full Text] [Related]
14. Citrate and celecoxib induce apoptosis and decrease necrosis in synergistic manner in canine mammary tumor cells.
Vahidi R; Safi S; Farsinejad A; Panahi N
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):22-8. PubMed ID: 26475384
[TBL] [Abstract][Full Text] [Related]
15. Low-dose doxorubicin with carotenoids selectively alters redox status and upregulates oxidative stress-mediated apoptosis in breast cancer cells.
Vijay K; Sowmya PR; Arathi BP; Shilpa S; Shwetha HJ; Raju M; Baskaran V; Lakshminarayana R
Food Chem Toxicol; 2018 Aug; 118():675-690. PubMed ID: 29920287
[TBL] [Abstract][Full Text] [Related]
16. The antiprogestins mifepristone and onapristone reduce cell proliferation in the canine mammary carcinoma cell line CMT-U27.
Guil-Luna S; Hellmén E; Sánchez-Céspedes R; Millán Y; Martín de las Mulas J
Histol Histopathol; 2014 Jul; 29(7):949-55. PubMed ID: 24500783
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic Identification of Anticancer Metabolites of Australian Propolis and Proteomic Elucidation of Its Synergistic Mechanisms with Doxorubicin in the MCF7 Cells.
Alsherbiny MA; Bhuyan DJ; Radwan I; Chang D; Li CG
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360606
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone receptor (GHR) RNAi decreases proliferation and enhances apoptosis in CMT-U27 canine mammary carcinoma cell line.
Pawłowski KM; Popielarz D; Szyszko K; Gajewska M; Motyl T; Król M
Vet Comp Oncol; 2012 Mar; 10(1):2-15. PubMed ID: 22235976
[TBL] [Abstract][Full Text] [Related]
20. VCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction.
Wu H; Liu S; Gong J; Liu J; Zhang Q; Leng X; Zhang N; Li Y
Cancer Lett; 2017 May; 393():22-32. PubMed ID: 28216375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
